Rezolute Inc (RZLT) Transcripts
Rezolute Inc RZ358 Phase 3 Planning Update Call Transcript
Jun 27, 2023
Rezolute Inc Annual Shareholders Meeting Transcript
May 25, 2023
Rezolute Inc RZ402 Phase 2 clinical program - Corporate Call Transcript
Mar 22, 2023
Rezolute Inc at Jefferies London Healthcare Conference Transcript
Nov 17, 2022
Rezolute Inc Annual Shareholders Meeting Transcript
Jun 16, 2022
Rezolute Inc Annual Shareholders Meeting Transcript
May 26, 2021
Rezolute's Keith Vendola, Ph 2b Initiated, RZ358, Congenital Hyperinsulinism Transcript
Feb 14, 2020
Rezolute's Keith Vendola Presents at 2020 Biotech Showcase in San Francisco Transcript
Jan 14, 2020